Reportstack

Global Endometriosis Market 2014-2018

 

Naperville, IL -- (ReleaseWire) -- 07/07/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Endometriosis Market 2014-2018 market report to its offering

Analysts forecast the Global Endometriosis market will grow at a CAGR of 2.86 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Endometriosis market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of endometriosis that are available in the market.

Global Endometriosis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the Global Endometriosis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- Abbvie Inc
- AstraZeneca plc
- Bayer AG
- Pfizer Inc

Other Prominent Vendors

- Astellas Pharma Inc
- Abbvie Inc
- Repros Therapeutics Inc
- Sanofi SA
- Takeda Pharmaceuticals Co. Ltd

Key Market Driver

- High Unmet Needs in the Market

For a full, detailed list, view our report

- Key Market Challenge
- Patent Expiries of Approved Drugs
- Key Market Trend
- Expected Launch of High-cost Therapies

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be
- What are the key market trends
- What is driving this market
- What are the challenges to market growth
- Who are the key vendors in this market space
- What are the market opportunities and threats faced by the key vendors
- What are the strengths and weaknesses of the key vendors

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Companies Mentioned

- Abbvie Inc
- AstraZeneca plc
- Bayer AG, Pfizer Inc
- Astellas Pharma Inc
- Abbvie Inc
- Repros Therapeutics Inc
- Sanofi SA
- Takeda Pharmaceuticals Co. Ltd

To view the table of contents for this market research report please visit http://www.reportstack.com/product/159830/global-endometriosis-market-2014-2018.html

About Endometriosis
Endometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining of the uterus, appear and grows outside the uterine cavity. Endometriosis mostly occurs in the fallopian tubes, ovaries, outer surface of the uterus, pelvic cavity, vagina, cervix, and bladder. Endometriosis has rarely been reported in more distant parts of the body such as the lungs, brain, and skin. The most common symptoms associated with endometriosis are pelvic pain, dysmenorrhea, excessive bleeding, and lower abdominal pain. Some of the uncommon symptoms of endometriosis are rectal bleeding and hematuria. The detection of endometriosis in women is difficult because of the common symptoms associated with it. Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic exam, and biopsy of the inner lining of the uterus. In a biopsy, the tissues from the inner lining of the uterus of the patient are taken and tested using the biomarkers for the presence of endometriosis. Endometriosis is an incurable disease and relapses after the primary treatment. Currently, the treatment options for endometriosis include the usage of hormone therapy and analgesics to control the disease.

Contact
Roger Campbell
contactus@reportstack.com
Naperville, IL
United States

Phone 888-789-6604